Search
01/12/2023
Proteomic comparison between non-purified cerebrospinal fluid and cerebrospinal fluid-derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia
Hirschberg, Y, Valle-Tamayo, N, Dols-Icardo, O, Engelborghs, S, Buelens, B, Vandenbroucke, RE, Vermeiren, Y, Boonen, K, Mertens, I. Proteomic comparison between non-purified cerebrospinal fluid and cerebrospinal fluid-derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia. Journal of Extracellular Vesicles. 2023; 12(12)DOI:10.1002/jev2.12383. PMID:38082559. IF:15.500(Q1/1D).
03/08/2023
Prevalence of treated patients with Alzheimer's disease: current trends and COVID-19 impact
Olazarán J., Carnero-Pardo C., Fortea J., Sánchez-Juan P., García-Ribas G., Vinuela, F, Martínez-Lage P., Boada M.. Prevalence of treated patients with Alzheimer's disease: current trends and COVID-19 impact. Alzheimers Research & Therapy. 2023; 15(1)DOI:10.1186/s13195-023-01271-0. PMID:37537656. IF:8.000(Q1/1D).
01/08/2023
Cortical microstructural changes predict tau accumulation and episodic memory decline in older adults harboring amyloid
Gagliardi, G, Rodriguez-Vieitez, E, Montal, V, Sepulcre, J, Diez, I, Lois, C, Hanseeuw, B, Schultz, AP, Properzi, MJ, Papp, KV, Marshall, GA, Fortea, J, Johnson, KA, Sperling, RA, Vannini, P. Cortical microstructural changes predict tau accumulation and episodic memory decline in older adults harboring amyloid. Communications Medicine. 2023; 3(1)DOI:10.1038/s43856-023-00324-7. PMID:37528163. IF:(Q/D).
26/07/2023
Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross-platform validation study
Hok-A-Hin, YS, Bolsewig, K, Ruiters, DN, Lleo, A, Alcolea, D, Lemstra, AW, van der Flier, WM, Teunissen, CE, del Campo, M. Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross-platform validation study. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2023; 15(3)DOI:10.1002/dad2.12456. PMID:37502019. IF:(Q/D).
25/07/2023
Blood Biomarkers in Neurodegenerative Diseases Implications for the Clinical Neurologist
Alcolea, D, Beeri, MS, Rojas, JC, Gardner, RC, Lleo, A. Blood Biomarkers in Neurodegenerative Diseases Implications for the Clinical Neurologist. NEUROLOGY. 2023; 101(4)DOI:10.1212/WNL.0000000000207193. PMID:36878698. IF:8.400(Q1/1D).
31/05/2023
Brain glucose metabolism and gray matter volume in retired professional soccer players: a cross-sectional [F-18]FDG-PET/MRI study
Aranha M.R., Coutinho A.M., Carneiro, CD, Pastorello B.F., Studart-Neto A., Guariglia C.C., Tsunemi M.H., Moreira, ELS, Ianof J.N., Anghinah R., Nitrini R., Cerri G.G., Fortea J., Buchpiguel C.A., Leite C.C.. Brain glucose metabolism and gray matter volume in retired professional soccer players: a cross-sectional [F-18]FDG-PET/MRI study. ARQUIVOS DE NEURO-PSIQUIATRIA. 2023; 81(05)DOI:10.1055/s-0043-1768666. PMID:37257463. IF:1.000(Q4/8D).